Given that our findings implicate PCBP2 in shaping key β cell gene expression and β cell function under broad conditions of glucose stimulation, targeting of this protein presents as an appealing potential therapeutic to combat T2D. Here, PCBP2 is linked to type 2 diabetes mellitus.